Want to join the conversation?
$XRX expects 3Q16 GAAP EPS of $0.14-0.16 and adjusted EPS of $0.26-0.28. For full-year 2016, $XRX reiterated its GAAP EPS guidance of $0.45-0.55 and adjusted EPS outlook of $1.10-1.20. The company continues to anticipate 2016 cash flow from operations of $0.95-1.2Bil and free cash flow of $600-850MM.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.